Cipher Pharmaceuticals Inc. (TSE:CPH – Get Rating) (NASDAQ:CPHR) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$2.27 and traded as high as C$2.27. Cipher Pharmaceuticals shares last traded at C$2.27, with a volume of 13,300 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Echelon Wealth Partners restated a “buy” rating on shares of Cipher Pharmaceuticals in a research note on Friday, May 13th.
Cipher Pharmaceuticals Stock Down 0.9 %
The business’s fifty day moving average price is C$2.27 and its 200 day moving average price is C$2.22. The company has a quick ratio of 2.25, a current ratio of 2.42 and a debt-to-equity ratio of 1.30. The firm has a market capitalization of C$57.21 million and a PE ratio of 5.49.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug.
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.